CORCEPT THERAPEUTICS INC Other Current Assets
CORCEPT THERAPEUTICS INC (CORT) had Other Current Assets of $8.36 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-07-29
- 2026-06-30: Other Assets, Current $8.36M.
- 2026-03-31: Other Assets, Current $6.38M.
- 2025-12-31: Other Assets, Current $7.10M.
- 2025-09-30: Other Assets, Current $6.00M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.36M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $6.38M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $7.10M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $6.00M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $7.47M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $24.87M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $6.08M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $4.58M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $9.13M 10-Q · filed 2024-07-29 | |
| 2024-03-31 | $18.36M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $5.88M 10-K · filed 2025-02-26 | $23.24M 10-Q · filed 2024-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |